SNDA · Sonida Senior Living, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Community Net Operating Income Margin, at-share non-GAAP | 28.9% | Q1 2026 | — |
| Pro forma community Net Operating Income Margin, at-share non-GAAP | 31.2% | Q1 2026 | — |
| Pro forma Revenue Per Available Unit (RevPAR) | $4,601 | Q1 2026 | — |
| Pro forma Revenue Per Occupied Unit (RevPOR) | $5,274 | Q1 2026 | — |
| Pro forma weighted average occupancy at-share for the Company's Same-Store Portfolio | 87.2% | Q1 2026 | — |
| Q1 2026 Adjusted EBITDA non-GAAP | $21.5M | Q1 2026 | — |
| Adjusted EBITDA non-GAAP | 53.8M | full year 2025 | — |
| Community Net Operating Income (same-store) non-GAAP | 65.2M | full year 2025 | — |
| Community Net Operating Income Margin (same-store) non-GAAP | 27.9% | full year 2025 | — |
| RevPAR (same-store) | $3,783 | full year 2025 | — |
| RevPOR (same-store) | $4,330 | full year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SNDA
this stock
Sonida Senior Living, Inc.
|
$1.89B | +22.1% | +19.2% | — | 5.8% |
|
HCA
HCA Healthcare, Inc.
|
$90.77B | -11.9% | +7.1% | 14.1 | 2.6% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$30.66B | -2.4% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$20.13B | +31.7% | -2.3% | 9.6 | 3.7% |
|
FMS
Fresenius Medical Care AG
|
$12.71B | +4.3% | — | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SNDA | -2.3% | -0.5% | +14.9% | -1.3% | +22.1% |
| SPY | +5.5% | +3.3% | +11.3% | +3.1% | +12.9% |
| vs SPY | -7.8% | -3.8% | +3.6% | -4.4% | +9.3% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.